Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine ...

This initiative is part of the brand’s commitment to providing guests with science-backed health and wellness services.

Alternatively, foods containing ingredients that naturally contain B3, such as poultry, red meat, fish, eggs, peanuts, brown ...

Investing.com -- Niagen Bioscience Inc (NASDAQ: NAGE) stock rose 2% after the company announced an exclusive worldwide commercial license agreement with Norway’s Haukeland University Hospital to ...

Niagen Bioscience, Inc., the global authority on NAD+ with a focus on the science of healthy aging, today announces that senior management will participate at the Roth 15 th Annual London ...

Niagen Bioscience Inc. has reached a significant milestone as its stock hit a 52-week high of 14.49 USD, with InvestingPro data showing the company maintains a "GREAT" overall financial health ...

The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full ...

Niagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...

Niagen Bioscience CFO, Ozan Pamir, will attend in-person one-on-one meetings with institutional investors throughout the conference.

The buzzy supplement is beloved by celebrities and starting to show up in skin care. But what can it actually do?

Discover why NAGE's Tru Niagen leads the NAD+ market, backed by health trends, growth potential, and a 20%+ stock upside.

Niagen Bioscience Inc. has reached a significant milestone as its stock hit a 52-week high of 14.49 USD, with InvestingPro data showing the company maintains a "GREAT" overall financial health score ...